Document:

gthp_ex1026

 

Exhibit 10.26

 

PROMISSORY NOTE

 

 

	

Original Issuance Date: September 6, 2018

 

	

Principal Amount: $50,000

 

 

THIS
PROMISSORY NOTE is duly authorized and validly Note of Guided
Therapeutics, Inc., a Delaware corporation, (the "Company"), having
its principal place of business at 5835 Peachtree Corners East,
Suite B, Norcross, Georgia 30092.

 

FOR
VALUE RECEIVED, the undersigned promises to pay to John Gould
("Holder"), with an address of 3854 43rd Ave NE, Seattle, WA 98105
the principal sum of $50,000.00 plus a $2,500 origination fee for a
total of FIFTY-TWO THOUSAND FIVE HUNDRED DOLLARS AND no CENTS
($52,500.00) in lawful money of the United States of America at
such place as Holder may designate in writing. The note shall earn
6% interest per annum payable to the Holder in quarterly
installments beginning 90 days after funds are received by the
Company for any amount of the principle plus loan origination fee
that is unpaid.

 

The entire unpaid principal balance due on this
Promissory Note (this "Note"), together with all accrued and unpaid
interest and loan origination fees, if any, at the choice of the
Holder, shall be due and payable in full from the funds received by
the Company from a financing of at least $2,000,000.00 DOLLARS (two
million U.S. dollars, zero cents) or, at the option of the Holder,
to be included as part of the Company's financing under the same
terms as the new investors with the most favorable terms making a
cash investment. If the Company does not complete a financing of at
least $2,000,000 within 90 days of the execution of this Promissory
Note, any unpaid amounts shall be due in full to the Holder and
shall accrue interest at 12% (instead of 6%) per annum from the
date thereof (90 days after execution) if not paid in
full.

 

Whether
or not the Holder of this Note converts the note into the next
Company financing, the Holder shall be granted 10 (ten) warrants
for each dollar of the Principle Amount loaned to the Company (or
500,000 warrants) under this Promissory Note. The warrants shall be
issued and vest upon the financing of at least $2,000,000.00 ("2
MILLION DOLLARS") and expire on the third anniversary of said
financing. The warrant exercise price shall be set at the same as
for warrants granted to the investors with the most favorable terms
as part of any $2 million dollar or more financing of the Company
or $.25, whichever is lower. The warrants shall have standard
anti-dilution features to protect the holder from dilution due to
down rounds of financing.

 

All
parties to this Note, including maker and any sureties, endorsers,
or guarantors, hereby waive protest, presentment, notice of
dishonor, and notice of acceleration of maturity and agree to
continue to remain bound for the payment of principal, interest and
all other sums due under this Note, notwithstanding any change or
changes by way of release, surrender, exchange, modification or
substitution of any security for this Note or by way of any
extension or extensions of time for the payment of principal and
interest, if any; and all such parties waive all and every kind of
notice of such change or changes and agree that the same may be
made without notice or consent of any of them.

 

This
Note shall be governed by, and construed in accordance with, the
laws of the State of Georgia, regardless of laws that might
otherwise govern under applicable principles of conflicts of
law.

 

IN
WITNESS WHEREOF, the undersigned has caused this instrument to be
duly executed the day and year first above written.

 

 

GUIDED
THERAPEUTICS, INC

By:
Gene S. Cartwright

Gene
S. Cartwright

CEOgthp_ex1027

  Exhibit 10.27

 

PROMISSORY NOTE

 

(Replaces deferred compensation of $207,110.86)

 

	

$207,110.86

	
 September
4, 2018

 

FOR
VALUE RECEIVED, Guided Therapeutics, loc., a Delaware corporation
(referred to hereinafter as "Maker" and "Company"), hereby promises
to pay to Mark Faupel ("Holder") the principal sum of Two Hundred
Seven Thousand, One Hundred Ten Dollars AND Eighty Six Cents
($207,110,86), plus accrued interest from the date hereof. The
unpaid principal amount under this Note ("Promissory Note") shall
accrue and pay simple interest at the rate of six percent (6%) per
annum, no compounding.

 

The
entire unpaid principal balance due on this Promissory Note (this
''Note''), together with all accrued and unpaid interest shall be
due and payable in full on the third anniversary of this
Note.

 

This
Note may be prepaid in full or in part at the time and from time to
time without penalty or premium. Each payment hereunder shall be
applied first to payment of interest then accrued and due on the
unpaid principal balance, with the remainder applied to the unpaid
principal. The undersigned shall be considered in default on this
Note if any payment of principal and accrued interest to Holder is
not received prior to or on the date the same becomes due.
Following and during the continuation of a default, Holder may,
without further notice to the undersigned, employ an attorney to
enforce Holder's rights and remedies under this Note in which case
the undersigned and any principal, surety, guarantor or endorser of
this Note hereby agree to pay to Holder all of Holder's reasonable
attorneys' fees in connection therewith. The failure by Holder to
exercise any such right or remedy shall not be a waiver or release
of such rights or remedies or the right to exercise any of them at
another time.

 

In
lieu of the partially forgiven deferred compensation, the Holder
will also receive 75,000 of the Company's stock options. The price
of the stock options shall be set at the market rate in accordance
with the Company's stock options Plan. 25,000 of the granted
options shall vest immediately, with the remaining 50,000 stock
options vesting monthly over the period of three years from the
grant date.

 

All
parties to this Note, including maker and any sureties, endorsers,
or guarantors, hereby waive protest, presentment, notice of
dishonor, and notice of acceleration of maturity and agree to
continue to remain bound for the payment of principal, interest and
all other sums due under this Note, notwithstanding any change or
changes by way of release, sun-ender, exchange, modification or
substitution of any security for this Note or by way of any
extension or extensions of time for the payment of principal and
interest; and all such parties waive all and every kind of notice
of such change or changes and agree that the same may be made
without notice or consent of any of them.

 

This
Note shall be governed by, and construed in accordance with, the
laws of the State of Georgia, regardless of laws that might
otherwise govern under applicable principles of conflicts of
law.

 

IN
WITNESS WHEREOF, the undersigned has caused this instrument to be
duly executed the day and year first above written.

  

	

 

	GUIDED
THERAPEUTICS, INC.	

 

	

 

	

 

	

 

	

 

	

	
By:  

	
/s/ Gene
S Cartwright  

	

 

	

 

	

 

	
Gene
S Cartwright	

 

	

 

	

 

	President
and CEOgtph_ex1028

Exhibit
10.28

 

 PROMISSORY
NOTE

 

(Replaces deferred compensation of $319,204.30)

 

	

$319,204.30

	
 September
4, 2018

 

FOR
VALUE RECEIVED, Guided Therapeutics, Inc., a Delaware corporation
(referred to hereinafter as “Maker” and
“Company”), hereby promises to pay to Gene Cartwright
(“Holder”) the principal sum of Three Hundred Nineteen
Thousand, Two Hundred Four Dollars and Thirty Cents ($319,204.30),
plus accrued interest from the date hereof. The unpaid principal
amount under this Note (“Promissory Note”) shall accrue
and pay simple interest at the rate of six percent (6%) per annum,
no compounding.

 

The
entire unpaid principal balance due on this Promissory Note (this
“Note”), together with all accrued and unpaid interest
shall be due and payable in full on the third anniversary of this
Note.

 

This
Note may be prepaid in full or in part at the time and from time to
time without penalty or premium. Each payment hereunder shall be
applied first to payment of interest then accrued and due on the
unpaid principal balance, with the remainder applied to the unpaid
principal. The undersigned shall be considered in default on this
Note if any payment of principal and accrued interest to Holder is
not received prior to or on the date the same becomes due.
Following and during the continuation of a default, Holder may,
without further notice to the undersigned, employ an attorney to
enforce Holder's rights and remedies under this Note in which case
the undersigned and any principal, surety, guarantor or endorser of
this Note hereby agree to pay to Holder all of Holder's reasonable
attorneys' fees in connection therewith. The failure by Holder to
exercise any such right or remedy shall not be a waiver or release
ofsuch rights or remedies or the right to exercise any of them at
another time.

 

In
lieu of partially forgiven deferred compensation, the Holder will
also receive 100,000 of the Company's stock options. The price of
the stock options shall be set at the market rate in accordance
with the Company's stock options Plan. 25,000 of the granted
options shall vest immediately, with the remaining 50,000 stock
options vesting monthly over the period of three years from the
grant date.

 

All
parties to this Note, including maker and any sureties, endorsers,
or guarantors, hereby waive protest, presentment, notice of
dishonor, and notice of acceleration of maturity and agree to
continue to remain bound for the payment of principal, interest and
all other sums due under this Note, notwithstanding any change or
changes by way of release, surrender, exchange, modification or
substitution of any security for this Note or by way of any
extension or extensions of time for the payment of principal and
interest; and all such parties waive all and every kind of notice
of such change or changes and agree that the same may be made
without notice or consent of any of them.

 

This
Note shall be governed by, and construed in accordance with, the
laws of the State of Georgia, regardless of laws that might
otherwise govern under applicable principles of conflicts of
law.

 

IN
WITNESS WHEREOF, the undersigned has caused this instrument to be
duly executed the day and year first above written.

 

	

 

	GUIDED
THERAPEUTICS, INC.	

 

	

 

	

 

	

 

	

 

	

	
By:  

	
/s/ Mark L
Faupel  

	

 

	

 

	

 

	
Mark L
Faupel  

	

 

	

 

	

 

	

COO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]